TUCSON, Ariz., Sept. 12, 2016 -- Medicine is being “fundamentally transformed” into an unaffordable, complex, adversarial, depersonalized labyrinth, writes dermatologist Melinda Woofter, M.D., of Granville, Ohio, in the fall issue of the Journal of American Physicians and Surgeons. Dr. Woofter is currently president of the Association of American Physicians and Surgeons (AAPS).
The direct reason for the unsustainable system, she writes, is government distortion of the marketplace, destroying cost transparency: “Government control of resources always leads to less for everyone. Without natural price signals for market adjustments, costs soar as resources are wrongly allocated, wasted, and squandered.”
In an effort to fix the problem it caused, government resorts to further price controls and still more coercion and restrictions, she explains. Solutions are difficult to find because “government powerholders and third-party cronies who benefit from this will not give up their stranglehold on medicine.”
Dr. Woofter recommends a short new primer analyzing the causes of the high costs and deteriorating quality of American medicine: Common Sense Medicine: Restoring the Patient/Physician Relationship by Jeff Danby. The key is not to pass more laws and regulations, but to restore natural price discovery between patients and doctors, Danby writes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail., or Melinda Woofter, M.D., [email protected]


CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 



